Paris, France

Andrew David Griffiths

This inventor holds 5 USPTO granted patents and 16 published patent applications and 11 EPO patents. Top assignees: Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris, Centre National De La Recherche Scientifique, Axlr, Satt Du Languedoc Roussillon. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew David Griffiths. Retrieved from https://idiyas.com/inventor/andrew-david-griffiths-wme3cj3e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andrew David Griffiths

Introduction

Andrew David Griffiths is a notable inventor based in Paris, France. He has made significant contributions to the field of biological diagnosis and proteomics, holding a total of five patents. His work focuses on developing methods and compositions that enhance the understanding and characterization of biological molecules.

Latest Patents

One of his latest patents is titled "Proteomic analysis with nucleic acid identifiers." This invention provides methods and compositions useful for labeling target molecules with origin-specific nucleic acid identifiers, such as barcodes. These identifiers can subsequently be used to identify, quantify, or characterize features or activities of target molecules originating from specific volumes. The target molecules can include polypeptides expressed by cells, where the nucleic acid molecules encoding these polypeptides are labeled with matching origin-specific nucleic acid identifiers.

Another significant patent is the "Method for detecting and/or characterizing tumor cells and associated apparatus." This invention relates to biological diagnosis in oncology. It involves a method and apparatus for detecting and characterizing tumor cells by identifying elements of the tumor cell secretome, particularly peptides or proteins, including tumor markers. The invention also encompasses methods for detecting and characterizing droplets of tumor cells and their preparation.

Career Highlights

Andrew has worked with prestigious institutions such as École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris and the Centre National de la Recherche Scientifique. His work in these organizations has contributed to advancements in scientific research and innovation.

Collaborations

Throughout his career, Andrew has collaborated with notable individuals, including Raphaël Clément, Li-Ming Doineau, and Clément Nizak. These collaborations have fostered a rich exchange of ideas and have furthered the impact of his inventions.

Conclusion

Andrew David Griffiths exemplifies the spirit of innovation in the field of biological sciences. His patents and contributions continue to influence research and development in proteomics and oncology. His work not only enhances scientific understanding but also paves the way for future advancements in medical diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…